Literature DB >> 17682844

Animal models of dilated cardiomyopathy for translational research.

F A Recchia1, V Lionetti.   

Abstract

Animal models of cardiovascular disease have proved critically important for the discovery of pathophysiological mechanisms and for the advancement of diagnosis and therapy. They offer a number of advantages, principally the availability of adequate healthy controls and the absence of confounding factors such as marked differences in age, concomitant pathologies and pharmacological treatments. Dilated cardiomyopathy (DCM) is the third cause of heart failure (HF) and is characterized by progressive ventricular dilation and functional impairment in the absence of coronary lesions and/or hypertension. Over the past thirty years, investigators have developed numerous small and large animal models to study this very complex syndrome. Genetically modified mice are the most widely and intensively utilized research animals and allow high throughput studies on DCM. However, to translate discoveries from basic science into medical applications, research in large animal models becomes a necessary step. An accurate large animal model of DCM is pacing-induced HF. It is obtained by continuous cardiac pacing at a frequency three- to fourfold higher than the spontaneous heart rate and is mostly applied to dogs, but also to pigs, sheep and monkeys. To date, this model can still be considered a gold standard in HF research.

Entities:  

Mesh:

Year:  2007        PMID: 17682844     DOI: 10.1007/s11259-007-0005-8

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  28 in total

1.  Actin mutations in dilated cardiomyopathy, a heritable form of heart failure.

Authors:  T M Olson; V V Michels; S N Thibodeau; Y S Tai; M T Keating
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

2.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

Review 3.  Learning from failure: congestive heart failure in the postgenomic age.

Authors:  Ivor J Benjamin; Michael D Schneider
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

4.  Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition.

Authors:  T Ryoke; Y Gu; L Mao; M Hongo; R G Clark; K L Peterson; J Ross
Journal:  Circulation       Date:  1999-10-19       Impact factor: 29.690

5.  Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure.

Authors:  Vincenzo Lionetti; Axel Linke; Margaret P Chandler; Martin E Young; Marc S Penn; Sachin Gupte; Chiara d'Agostino; Thomas H Hintze; William C Stanley; Fabio A Recchia
Journal:  Cardiovasc Res       Date:  2005-03-03       Impact factor: 10.787

6.  Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure.

Authors:  Biao Lei; Vincenzo Lionetti; Martin E Young; Margaret P Chandler; Chiara d'Agostino; Elaine Kang; Martin Altarejos; Ken Matsuo; Thomas H Hintze; William C Stanley; Fabio A Recchia
Journal:  J Mol Cell Cardiol       Date:  2004-04       Impact factor: 5.000

7.  Sequential echocardiographic-Doppler assessment of left ventricular remodelling and mitral regurgitation during evolving experimental heart failure.

Authors:  R J Howard; G W Moe; P W Armstrong
Journal:  Cardiovasc Res       Date:  1991-06       Impact factor: 10.787

8.  Evaluation of ventricular contractility indexes in the dog with left ventricular dysfunction induced by rapid atrial pacing.

Authors:  D E Morgan; C W Tomlinson; A K Qayumi; P M Toleikis; B McConville; W R Jamieson
Journal:  J Am Coll Cardiol       Date:  1989-08       Impact factor: 24.094

9.  Dissociation between regional dysfunction and beta-adrenergic receptor signaling in heart failure.

Authors:  T Anzai; N C Lai; M Gao; H K Hammond
Journal:  Am J Physiol       Date:  1998-10

10.  Expression profiling of human idiopathic dilated cardiomyopathy.

Authors:  Rafal Grzeskowiak; Henning Witt; Mario Drungowski; Rolf Thermann; Steffen Hennig; Andreas Perrot; Karl J Osterziel; Dirk Klingbiel; Stefanie Scheid; Rainer Spang; Hans Lehrach; Patricia Ruiz
Journal:  Cardiovasc Res       Date:  2003-08-01       Impact factor: 10.787

View more
  24 in total

1.  Translational research: current status, challenges and future strategies.

Authors:  Dale Yu
Journal:  Am J Transl Res       Date:  2011-09-12       Impact factor: 4.060

Review 2.  Model-specific selection of molecular targets for heart failure gene therapy.

Authors:  Michael G Katz; Anthony S Fargnoli; Catherine E Tomasulo; Louella A Pritchette; Charles R Bridges
Journal:  J Gene Med       Date:  2011-10       Impact factor: 4.565

3.  Cloning, expression, and bioinformatics analysis of the sheep CARP gene.

Authors:  Guoda Ma; Haiyang Wang; You Li; Lili Cui; Yudong Cui; Qingzhang Li; Keshen Li; Bin Zhao
Journal:  Mol Cell Biochem       Date:  2013-03-10       Impact factor: 3.396

Review 4.  Childhood adversity and mechanistic links to hypertension risk in adulthood.

Authors:  Ijeoma E Obi; Kasi C McPherson; Jennifer S Pollock
Journal:  Br J Pharmacol       Date:  2019-03-03       Impact factor: 8.739

5.  From ischemic conditioning to 'hyperconditioning': clinical phenomenon and basic science opportunity.

Authors:  Peter Whittaker; Karin Przyklenk
Journal:  Dose Response       Date:  2014-10-20       Impact factor: 2.658

6.  Cell-to-cell variability in troponin I phosphorylation in a porcine model of pacing-induced heart failure.

Authors:  Dániel Czuriga; Attila Tóth; Eniko T Pásztor; Agnes Balogh; Andrea Bodnár; Eniko Nizsalóczki; Vincenzo Lionetti; Fabio A Recchia; István Czuriga; István Edes; Zoltán Papp
Journal:  Basic Res Cardiol       Date:  2012-01-12       Impact factor: 17.165

7.  Chronic heart failure selectively induces regional heterogeneity of insulin-responsive glucose transporters.

Authors:  Bruce Ware; Marie Bevier; Yoshinori Nishijima; Suzanne Rogers; Cynthia A Carnes; Véronique A Lacombe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-17       Impact factor: 3.619

Review 8.  Small mammalian animal models of heart disease.

Authors:  Paula Camacho; Huimin Fan; Zhongmin Liu; Jia-Qiang He
Journal:  Am J Cardiovasc Dis       Date:  2016-09-15

Review 9.  Vascular dysfunction in idiopathic dilated cardiomyopathy.

Authors:  Santiago Roura; Antoni Bayes-Genis
Journal:  Nat Rev Cardiol       Date:  2009-07-28       Impact factor: 32.419

Review 10.  Small-animal SPECT and SPECT/CT: application in cardiovascular research.

Authors:  Reza Golestani; Chao Wu; René A Tio; Clark J Zeebregts; Artiom D Petrov; Freek J Beekman; Rudi A J O Dierckx; Hendrikus H Boersma; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.